Europe Cancer Targeted Therapy Market Report Outlook (2021–2031)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
Report Content: Market Scope, Market Segmentation, Market Dynamics, and Competitive Analysis

Report Coverage:
  • Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Immune Checkpoint Inhibitors, Cancer Vaccines, Gene Therapy, Other Therapy Types)
  • Indication (Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications)
  • End User (Hospital Pharmacies, Retail Pharmacies, Online Stores)

No. of Pages: 115
Report Code: BMIPUB00033512
Category: Life Sciences
Europe Cancer Targeted Therapy Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Cancer Targeted Therapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Cancer Targeted Therapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Cancer Targeted Therapy Market Regional Analysis

6.2 Europe Cancer Targeted Therapy Market Revenue 2021-2031 (US$ Million)
6.3 Europe Cancer Targeted Therapy Market Forecast Analysis

7. Europe Cancer Targeted Therapy Market Analysis – by Therapy Type

7.1 Monoclonal Antibodies
  • 7.1.1 Overview
  • 7.1.2 Monoclonal Antibodies: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Tyrosine Kinase Inhibitors
  • 7.2.1 Overview
  • 7.2.2 Tyrosine Kinase Inhibitors: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Immune Checkpoint Inhibitors
  • 7.3.1 Overview
  • 7.3.2 Immune Checkpoint Inhibitors: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Cancer Vaccines
  • 7.4.1 Overview
  • 7.4.2 Cancer Vaccines: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Gene Therapy
  • 7.5.1 Overview
  • 7.5.2 Gene Therapy: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Types
  • 7.6.1 Overview
  • 7.6.2 Other Therapy Types: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Cancer Targeted Therapy Market Analysis – by Indication

8.1 Blood Cancer
  • 8.1.1 Overview
  • 8.1.2 Blood Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
  • 8.2.1 Overview
  • 8.2.2 Lung Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
  • 8.3.1 Overview
  • 8.3.2 Breast Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
  • 8.4.1 Overview
  • 8.4.2 Colorectum Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
  • 8.5.1 Overview
  • 8.5.2 Prostate Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
  • 8.6.1 Overview
  • 8.6.2 Stomach Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
  • 8.7.1 Overview
  • 8.7.2 Cervical Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
  • 8.8.1 Overview
  • 8.8.2 Liver and Intrahepatic Bile Duct Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
  • 8.9.1 Overview
  • 8.9.2 Thyroid Cancer: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
  • 8.10.1 Overview
  • 8.10.2 Other Indications: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Cancer Targeted Therapy Market Analysis – by End User

9.1 Hospital Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hospital Pharmacies: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacies: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
  • 9.3.1 Overview
  • 9.3.2 Online Stores: Europe Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Cancer Targeted Therapy Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Cancer Targeted Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 Europe Cancer Targeted Therapy Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Belgium: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Belgium: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.1.2 Belgium: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.1.3 Belgium: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.2 Austria: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 Austria: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.2.2 Austria: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.2.3 Austria: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.3 Finland: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 Finland: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.3.2 Finland: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.3.3 Finland: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.4 Denmark: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.4.1 Denmark: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.4.2 Denmark: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.4.3 Denmark: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.5 Greece: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.5.1 Greece: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.5.2 Greece: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.5.3 Greece: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.6 Poland: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.6.1 Poland: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.6.2 Poland: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.6.3 Poland: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.7 Romania: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.7.1 Romania: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.7.2 Romania: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.7.3 Romania: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.8 Russia: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.8.1 Russia: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.8.2 Russia: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.8.3 Russia: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.9 Ukraine: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.9.1 Ukraine: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.9.2 Ukraine: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.9.3 Ukraine: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.10 Czech Republic: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.10.1 Czech Republic: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.10.2 Czech Republic: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.10.3 Czech Republic: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.11 Slovakia: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.11.1 Slovakia: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.11.2 Slovakia: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.11.3 Slovakia: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.12 Bulgaria: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.12.1 Bulgaria: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.12.2 Bulgaria: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.12.3 Bulgaria: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.13 Italy: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.13.1 Italy: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.13.2 Italy: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.13.3 Italy: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.14 Luxembourg: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.14.1 Luxembourg: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.14.2 Luxembourg: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.14.3 Luxembourg: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.15 Germany: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.15.1 Germany: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.15.2 Germany: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.15.3 Germany: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.16 Switzerland: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.16.1 Switzerland: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.16.2 Switzerland: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.16.3 Switzerland: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.17 France: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.17.1 France: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.17.2 France: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.17.3 France: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.18 Netherlands: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.18.1 Netherlands: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.18.2 Netherlands: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.18.3 Netherlands: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.19 Norway: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.19.1 Norway: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.19.2 Norway: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.19.3 Norway: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.20 Portugal: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.20.1 Portugal: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.20.2 Portugal: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.20.3 Portugal: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.21 Spain: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.21.1 Spain: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.21.2 Spain: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.21.3 Spain: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.22 Sweden: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.22.1 Sweden: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.22.2 Sweden: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.22.3 Sweden: Europe Cancer Targeted Therapy Market Breakdown, by End User
  • 10.2.1.23 United Kingdom: Europe Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.23.1 United Kingdom: Europe Cancer Targeted Therapy Market Breakdown, by Therapy Type
    • 10.2.1.23.2 United Kingdom: Europe Cancer Targeted Therapy Market Breakdown, by Indication
    • 10.2.1.23.3 United Kingdom: Europe Cancer Targeted Therapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Astellas Pharma Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eli Lilly and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Novartis AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Merck KGaA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Johnson & Johnson
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 AstraZeneca
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Pfizer Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Bristol Myers Squibb
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 F. Hoffmann-La Roche Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 AbbVie
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Cancer Targeted Therapy Market

  • Astellas Pharma Inc
  • Eli Lilly and Co
  • Novartis AG
  • Merck KGaA
  • Johnson & Johnson
  • AstraZeneca
  • Pfizer Inc
  • Bristol Myers Squibb
  • F. Hoffmann-La Roche Ltd
  • AbbVie

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)